Stock analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a report released on Saturday. The brokerage set a “sell” rating on the stock.
Ayala Pharmaceuticals Price Performance
ADXS opened at $0.03 on Friday. Ayala Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $1.49. The company has a market cap of $1.16 million, a P/E ratio of 0.00 and a beta of 1.72. The firm’s 50-day moving average price is $0.04 and its 200-day moving average price is $0.18.
Ayala Pharmaceuticals Company Profile
Read More
- Five stocks we like better than Ayala Pharmaceuticals
- Top Biotech Stocks: Exploring Innovation Opportunities
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- What Are Dividend Contenders? Investing in Dividend Contenders
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.